
Texas Capital Bancshares Inc.
TCBIO | NASDAQ
$19.10
-$0.40 (-2.08%)
Sep 22, 2026, 2:30 PM ET · Market open
Fiscal Year Period Ending | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 | FY 2019 Dec 30, 2019 |
|---|---|---|---|---|---|---|
Revenue | 1.76B | 1.79B | 1.25B | 987.05M | 1.18B | 1.44B |
Cost of Revenue | 895.25M | 787.8M | 334.48M | 77.75M | 446.09M | 460.59M |
Gross Profit | 865.35M | 1B | 910.76M | 909.3M | 731.72M | 974.59M |
Operating Income | 107.06M | 246.6M | 431.76M | 338.06M | 91.95M | 396.31M |
Interest Income | 1.73B | 1.63B | 1.14B | 876.59M | 1.04B | 1.35B |
Pretax Income | 107.06M | 246.6M | 431.76M | 338.06M | 91.95M | 396.31M |
Net Income | 77.51M | 189.14M | 332.48M | 253.94M | 66.29M | 312.02M |
Selling & General & Admin | 512.28M | 522.33M | 483.54M | 381.23M | 390.07M | 446.76M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 246.01M | 234.62M | -4.54M | 190.02M | 249.71M | 131.52M |
Operating Expenses | 758.29M | 756.95M | 479.01M | 571.25M | 639.77M | 578.28M |
Interest Expense | 828.25M | 715.8M | 268.48M | 107.75M | 188.09M | 385.59M |
Selling & Marketing Expenses | 22.35M | 25.85M | 32.39M | 10.01M | 23.58M | 53.36M |
Cost & Expenses | 1.65B | 1.54B | 813.49M | 649M | 1.09B | 1.04B |
Income Tax Expense | 29.55M | 57.45M | 99.28M | 84.12M | 25.66M | 84.3M |
Shares Outstanding (Basic) | 46.56M | 48.01M | 50.46M | 50.58M | 50.43M | 50.29M |
Shares Outstanding (Diluted) | 46.99M | 48.61M | 51.05M | 51.14M | 50.58M | 50.42M |
EPS (Basic) | 1.29 | 3.58 | 6.25 | 4.65 | 1.12 | 6.23 |
EPS (Diluted) | 1.28 | 3.54 | 6.18 | 4.60 | 1.12 | 6.21 |
EBITDA | 161.29M | 287.07M | 477.04M | 431.46M | 166.87M | 433.58M |
EBIT | 107.06M | 246.6M | 431.76M | 338.06M | 91.95M | 396.31M |
Depreciation & Amortization | 54.23M | 40.47M | 45.28M | 93.41M | 74.93M | 37.27M |
Add to Watchlist
Select watchlists to add or remove TCBIO